Arch Therapeutics Inc Asset Turnover Ratio (ARTH), as of third quarter 2024, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Arch Therapeutics Inc   (ARTH)
 

Arch Therapeutics Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Arch Therapeutics Inc asset turnover ratio, the ability of Arch Therapeutics Inc 's assets to generate revenue in the third quarter 2024, increased sequentially to 0.09 in the third quarter (Jun 30 2024), yet the ratio remained below the average, as ARTH's position remain challenging.

Within sector 172 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the Third Quarter 2024 compared to the preceding quarter from 0 to 3317.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ARTH Asset Turnover Ratio (Jun 30 2024)
III. Quarter		 (Mar 31 2024)
II. Quarter		 (Dec 31 2023)
I. Quarter		 (Sep 30 2023)
IV. Quarter		 (Jun 30 2023)
III. Quarter
Y / Y Asset Change -10.65 % -3.31 % 6.17 % -24.79 % -0.56 %
Y / Y Revenue Change 132.55 % 91.34 % 632.58 % 2423.37 % 112.31 %
Asset Turnover Ratio (TTM) 0.09 0.08 0.07 0.04 0.02
ARTH's Total Ranking # 3317 # 0 # 0 # 3502 # 0
Seq. Asset Change -9.24 % -15.47 % -6.96 % 25.18 % -1.79 %
Seq. Revenue Change -2.99 % -30.53 % 16.07 % 197.27 % -20.18 %



Asset Turnover Ratio Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 173
Healthcare Sector # 506
Overall Market # 3317

Asset Turnover Ratio Statistics
High Average Low
9.09 3.86 0.04
(Dec 31 2022)   (Sep 30 2023)




ARTH Company Profile • Back to ARTH Efficiency Comparisons • Compare ARTH Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Jun 30 2024, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Jun 30 2024 Assets at quarter ending Jun 30 2024
Moderna Inc   0.29 $ 5,050.000  Millions$ 17,571.250  Millions
Ionis Pharmaceuticals Inc   0.29 $ 813.459  Millions$ 2,844.775  Millions
Bioadaptives Inc   0.28 $ 0.036  Millions$ 0.125  Millions
Vanda Pharmaceuticals Inc   0.28 $ 182.022  Millions$ 648.525  Millions
Scpharmaceuticals Inc   0.28 $ 24.048  Millions$ 86.123  Millions
Alpha Teknova Inc   0.27 $ 34.122  Millions$ 125.785  Millions
Tarsus Pharmaceuticals Inc   0.26 $ 83.374  Millions$ 314.986  Millions
Repare Therapeutics Inc   0.26 $ 68.683  Millions$ 259.684  Millions
Beam Therapeutics Inc   0.26 $ 352.567  Millions$ 1,342.827  Millions
Schrodinger Inc   0.26 $ 197.946  Millions$ 755.809  Millions
Adaptive Biotechnologies Corporation  0.26 $ 168.766  Millions$ 646.003  Millions
Pfizer Inc  0.25 $ 55,642.000  Millions$ 219,702.500  Millions
Acutus Medical Inc   0.25 $ 13.618  Millions$ 53.957  Millions
Carisma Therapeutics Inc   0.25 $ 20.721  Millions$ 82.368  Millions
Standard Biotools Inc   0.25 $ 134.825  Millions$ 537.188  Millions
Travere Therapeutics Inc   0.25 $ 177.644  Millions$ 709.108  Millions
Dynavax Technologies Corporation  0.25 $ 248.695  Millions$ 993.229  Millions
Intelligent Bio Solutions Inc   0.25 $ 3.112  Millions$ 12.468  Millions
Xenetic Biosciences Inc   0.25 $ 2.520  Millions$ 10.248  Millions
Cryoport inc   0.24 $ 225.606  Millions$ 938.398  Millions
Marker Therapeutics inc   0.24 $ 3.727  Millions$ 15.595  Millions
Nektar Therapeutics  0.24 $ 93.157  Millions$ 394.906  Millions
Butterfly Network Inc   0.24 $ 70.320  Millions$ 298.963  Millions
T2 Biosystems Inc   0.23 $ 7.164  Millions$ 31.139  Millions
Fulgent Genetics Inc   0.23 $ 289.311  Millions$ 1,263.962  Millions
Innovative Eyewear Inc   0.23 $ 1.530  Millions$ 6.752  Millions
Repligen Corp  0.22 $ 619.834  Millions$ 2,768.404  Millions
Insmed Inc  0.22 $ 310.753  Millions$ 1,405.981  Millions
Bio rad Laboratories Inc   0.22 $ 2,561.704  Millions$ 11,623.338  Millions
Valion Bio Inc   0.22 $ 1.113  Millions$ 5.058  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.